UK
UK
Nov-08
Cardiovascular Pharmacoepidemiology
Read moreSep-08
Cardiovascular Pharmacoepidemiology
Read moreAug-08
Cardiovascular Pharmacoepidemiology
Read moreAug-08
Cardiovascular Endocrinology Pharmacoepidemiology
Read moreMay-08
Jan-08
Dec-07
Cardiovascular Neurology Other Vascular Respiratory
Read moreSep-07
Sep-07
Dec-06
Nov-06
Cardiovascular Pharmacoepidemiology
Read more| Date | Title | Categories | Type | |
|---|---|---|---|---|
| Nov-08 | Age threshold for routine aspirin treatment to prevent cardiovascular disease in patients without diabetes | Abstract | Read more | |
| Sep-08 | Trends in Survival Following Acute Myocardial Infarction in the United Kingdom: Relation to Changes in Prescribing of Evidence-Based Medication in Primary Care | Abstract | Read more | |
| Aug-08 | Clinical outcomes associated with anticoagulant therapies in patient with incident heart failure: A retrospective analysis of a population based database | Abstract | Read more | |
| Aug-08 | Association between serious ischemic cardiac outcomes and medications used to treat diabetes | Full Article | Read more | |
| May-08 | Trends in survival following an acute myocardial infarction in the UK in relation to changes in prescribing of evidence-based medication in primary care | Abstract | Read more | |
| May-08 | Changing patterns of chronic heart failure treatment in British primary care | Abstract | Read more | |
| Jan-08 | Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study | Full Article | Read more | |
| Dec-07 | The Risk of Acute Coronary Syndromes, Cerebrovascular Accidents and Deep Vein Thromboses in People with Idiopathic Pulmonary Fibrosis and the General Population | Abstract | Read more | |
| Sep-07 | Contribution of changes in incidence and mortality to trends in the prevalence of coronary heart disease in the UK: 1996 2005 | Full Article | Read more | |
| Sep-07 | Clinical utility of indentifying metabolic syndrome (MetS) in patients with type 2 diabetes for primary cardiovascular disease (CVD) prevention: a population-based study | Abstract | Read more | |
| Dec-06 | Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile | Full Article | Read more | |
| Nov-06 | Antihypertensive drug budget impact of the Angiotensin II Receptor Blockers (ARB) in the UK | Abstract | Read more |
